Chiron launches HIV vaccine trial
January 17 2004 1:00 AM ET
Biotechnology company Chiron announced the launch Thursday of human clinical trials of its two-part experimental HIV vaccine, the Los Angeles Times reports. Participants in the trials will first receive a DNA-based vaccine containing two key HIV proteins to prime the immune system into recognizing the invading virus and a booster shot aimed at further stimulating an immune response. An initial two-year safety trial will involve 168 HIV-negative volunteers in St. Louis, Seattle, and Nashville. Additional efficacy tests will be conducted after the safety study.
- WATCH: Dodger Stadium Reacts to Same-Sex Couple on Kiss Cam
- Newly Out Fox Contributor Isn't Very Concerned About Gay Rights
- Could National Marriage Equality Mean the End of Gay Culture?
- Meet Ireland's Marriage Equality Benefactor: American Billionaire Chuck Feeney
- WATCH: Can the GOP Presidential Field Get Any More Antigay?
- #TBT: They Died in the Closet